Skip to main content
. Author manuscript; available in PMC: 2012 Jun 20.
Published in final edited form as: J Infect Dis. 2008 Aug 1;198(3):444–451. doi: 10.1086/589718

Figure 1.

Figure 1

Distribution of levels of antibody to NIE, as determined by ELISA (A) and luciferase immunoprecipitation systems (LIPS) assay (B), in patients infected with Strongyloides stercoralis, filaria, or helminths and in healthy, uninfected control subjects (normals). The 6 helminth-infected patients were a subset of the filaria-infected group. C, Levels of antibody to S. stercoralis immunoreactive antigen, as determined by LIPS assay. A significant difference between S. stercoralis–infected and uninfected control subjects was found for all 3 assays (P < .0001; Mann-Whitney U test). No significant difference was found between the control subjects and the filaria-infected patients for the NIE LIPS assay (P = .6909; Mann-Whitney U test).